Select Page

Nick Tate

Nick TateNick Tate Senior Editorial Manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

Nick Tate is the senior editorial manager for Bold Profits Daily, Profits Unlimited and Paul Mampilly’s other premium trading publications.

As a best-selling author, seasoned journalist and TV commentator specializing in health care, finance and biotech, Nick is all about big ideas and innovations — always keeping his followers informed on the next big thing.

His work has appeared in The Miami Herald, The Atlanta Journal-Constitution, South Florida Business Journal, Newsmax Magazine, South Florida Sun Sentinel, Boston Herald, and on Newsmax TV and the Al Jazeera network.

His top-selling book, the ObamaCare Survival Guide, was on the Publishers Weekly and The New York Times best-sellers lists for 22 weeks — reaching No. 1 on The Times list for paperback advice books.

Tate also co-authored DaVinci’s Baby Boomer Survival Guide: Live, Prosper, and Thrive in Your Retirement. And he published two other books — the Encyclopedia of Natural Healing and The Sick Building Syndrome — following a year-long journalism fellowship at the Harvard School of Public Health.

Tate’s three-decades-long commitment to keeping the public well-informed is why Banyan Hill Publishing recruited him in 2018 to join Paul Mampilly’s team. You can now read Nick’s weekly analysis in Bold Profits Daily as he guides over 130,000 readers on the best ways to grow their wealth.

Nick Tate's Articles

pet industry ETF and pet spending Pet Spending Hits $75 Billion – Invest in Pet ETF PAWZ September 12, 2019 Bold Profits Daily, Investment Opportunities - Pet spending in the U.S. exceeds $75 billion a year — more than the combined gross domestic product of 39 other countries. And that figure will grow by double digits over the next three to five years. Here’s how to turn this growing mega pet trend into profits for your portfolio.
opioid industry needs to stop Invest in New Painkiller Technology “Disruptifying” The $25 Billion Opioid Industry August 29, 2019 Bold Profits Daily, Investment Opportunities, Technology - Biotech firms and startups are creating safer alternatives to pain pills, “disruptifying” the growing $25 billion opioid industry. With Big Pharma painkiller-makers on the run from regulators and lawsuits, innovative companies are stepping into the gap. Here’s how to turn Big Pharma’s pain into your gain, profiting from the innovators who are all over it.
Researchers have created microscopic robots that can deliver painkillers and cancer drugs, and even eat up artery-clogging cholesterol inside the body. Here’s the best way to play the rise of medical minibots for double-digit profits. 2 Ways to Invest in The Medical Robot Market Before it Skyrockets August 15, 2019 Bold Profits Daily, Investment Opportunities, Technology - Researchers have created microscopic robots that can deliver painkillers and cancer drugs, and even eat up artery-clogging cholesterol inside the body. Here’s the best way to play the rise of medical minibots for double-digit profits.
Fintech Fix for Capital One-Like Cyber Hacks to Surge 1,842% August 2, 2019 Bold Profits Daily, Investment Opportunities, Technology - This week’s Capital One hack spotlights the need to take precautions against cyber thieves. But it also highlights a great investment strategy that leverages a fintech fix — blockchain technology — that could mean the end of risky credit card and bank account hacks.
Your Way to 93% Biotech Gains Through “Merger Mania” July 19, 2019 Bold Profits Daily, Investment Opportunities - Small biotech startups are beating Big Pharma to the punch in developing new “precision medicine” drugs, fueling a wave of 2019 mergers and acquisitions. Here’s the best way to play the biotech-pharma merger mania for double-digit profits.
Biotech is Leading the $8 Billion IPO Surge July 5, 2019 Bold Profits Daily, Investment Opportunities - Last year was a high-water mark for biotech companies going public — with 60. But the Class of 2019 is on track to beat that record, with 38 biotech IPOs since January 1. Here’s how to capitalize on the red-hot biotech IPO market.
Today, Bold Profits IPO analyst Hudson Cashdan talks up the new Chewy public offering and tells Nick Tate why Beyond Meat has been such a superstar stock since going public on May 1. Plus: a preview of Bold Profits’ new IPO Speculator service. Chewy and Beyond Meat Spotlight Sizzling IPO Opportunities June 14, 2019 Bold Profits Daily, Investment Opportunities, Stocks - Today, Bold Profits IPO analyst Hudson Cashdan talks up the new Chewy public offering and tells Nick Tate why Beyond Meat has been such a superstar stock since going public on May 1. Plus: a preview of Bold Profits’ new IPO Speculator service.
Artificially intelligent robots and other “thinking” machines are entering the workforce in health care, banking and retail. They can not only help you with your health, finances and store purchases, but offer a great investment opportunity too. Meet Pepper: The New Face of AI Robotics June 7, 2019 Bold Profits Daily, Investment Opportunities, Technology - Artificially intelligent robots and other “thinking” machines are entering the workforce in health care, banking and retail. They can not only help you with your health, finances and store purchases, but offer a great investment opportunity too.
271% Gain in 2 Weeks From Biotech Rebound May 31, 2019 Bold Profits Daily, Investment Opportunities, Trading Strategies - See how you could gain 271% in two weeks using Paul’s Wall Street insider strategy, designed to beat market manipulators at their own game.
This one trick that market manipulators use to drive stock prices down can help you spot stocks as they're about to rebound. Buy Into Stocks That Are Rebounding for Rocket Returns May 24, 2019 Bold Profits Daily, Stocks, Trading Strategies - “Buy low, sell high.” It’s investors’ mantra. But this one trick that market manipulators use to drive stock prices down can help you spot the right ones at the right time — just as they’re about to skyrocket.

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

I am up $20,070 in closed positions from Feb. 18 through March 7.

- Bob Rowe

I started your system in December … I am ahead $29,000 … I put total faith in you and your system and it has worked for me very nicely. Thanks again I sure like your humble approach about this whole thing

- Dale Leiffer

I have made a little over $4,000 while being cautious.

- Chuck Goss